A micro-costing study of mass-spectrometry based quantitative proteomics testing applied to the diagnostic pipeline of mitochondrial and other rare disorders

Abstract Background Mass spectrometry-based quantitative proteomics has a demonstrated utility in increasing the diagnostic yield of mitochondrial disorders (MDs) and other rare diseases. However, for this technology to be widely adopted in routine clinical practice, it is crucial to accurately esti...

Descrición completa

Detalles Bibliográficos

Principais autores:	Francisco Santos Gonzalez, Daniella H. Hock, David R. Thorburn, Dylan Mordaunt, Nicholas A. Williamson, Ching-Seng Ang, David A. Stroud, John Christodoulou, Ilias Goranitis
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2024-11-01
Series:	Orphanet Journal of Rare Diseases
Assuntos:	Proteomics Mitochondrial disorders Micro-costing Functional genomics Health economics
Acceso en liña:	https://doi.org/10.1186/s13023-024-03462-w
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!